BioCentury Inc.’s Post

Early Bird rates for Bio€quity Europe ends Friday - register now to save! With 60+ biotechs already confirmed to present, this year’s event in San Sebastián is expected to sell out, again. In fact, we are on track to exceed last year, when 300 VCs, 330 CEOs, and 150 C-level executives joined. This year we will gather in Basque Country to discuss how biotechs can rise above the noise to attract the right investors, partners, and talent. I hope you will join BioCentury Inc., EBD Group, and Regional Host Committee Chair Ysios Capital in one of the culinary capitals of the world. Register for #BioEquityEurope by Friday to save: https://ow.ly/lkOl50QyYeS Learn more, including the schedule-at-a-glance and presenting companies you will meet: https://ow.ly/8B5c50QyYeR #biotech #biopharma

We were proud to be selected as one of the Fierce Biotech Fierce 15 2024 Honorees. We asked ourselves – what makes us fierce? Here is what our team said #3. We are ambitious: We are driven by our shared mission to discover, develop and deliver impactful medicines to patients using cutting edge science. We are motivated to push boundaries and think big as we tackle challenges we confront as a company. We take a proactive approach towards research, and we are intentional in setting our short-term and long-term goals. Read more about how OMassians are transforming lives together, our values and our team HERE: https://lnkd.in/ddaju6xf #innovation #biotech #drugdiscovery

Yesterday Sixfold Bioscience also presented to the Society for Medicines Research on ‘The Innovation Landscape’ where UK discovery productivity and growth funding were on the agenda. Thanks to the SMR and Pharmidex, High Force Research Ltd and WuXi AppTec, session chairs from LifeArc, TherapeutAix who made the discussions worthwhile. It seems we all find innovation growth is a tough but irresistable journey - yes we do need more and varied funding models (a shout to Pioneer Group, MSD Pharma GmbH, BroadOak Capital Partners and Medicines Discovery Catapult here) and we all look forward to the economic ‘green shoots’.  As data tools accelerate the pace of innovation, let’s also recognise that we’ll face tough competition to attract and retain the UK and international scientific talent to make growth possible.

This morning EuropaBio - the European Association for Bioindustries co-hosted a roundtable discussion with MEP Fulvio Martusciello. The discussion with key stakeholders from the healthcare biotechnology ecosystem, guided by the recently published Charles River Associates study, covered how the GPL will impact the innovation ecosystem and what remains crucial to keep in mind going into the upcoming election cycle and beyond. Some key takeaways from the discussion include: 🔵 Predictability remains of critical importance to retaining the innovative companies that are Europe's strongest asset. 🔵 A baseline of incentives is necessary to foster a dynamic market in which smaller companies can align with the innovation cycle while maintaining their competitiveness. 🔵 Simplifying the regulatory processes to ensure that medicinal products arrive on the market as fast as possible for patients. ➡ Read more https://lnkd.in/eHZMiaHU

End-of-Year Rally for European Private Biotechs: November saw biotech financing appearing to slow down as we reach the holiday season, following a peak in September. In total, the market closed 50 rounds in November with a total value of USD 1.42bn. The number of rounds was lower than the previous month and the value of funding also fell. Conversely, Europe saw an increase in funding value compared to October – USD 163 higher. US-based Terremoto Biosciences secured the largest deal of the month through their Series B round worth USD 175m. Read the Biotechgate Financing Summary: https://lnkd.in/dVnfPaX

📈 Everyone from #polishbiotech ecosystem is super fascinated with recent financial successes of #biotech companies such as Celon Pharma S.A. , NanoGroup S.A. or Pure Biologics (detailed analysis in articles cited in comm. 👇) I am also glad about above mentioned results as they are showcasing that investors don’t need to be afraid of biotech companies and it builds their TRUST - the most valuable asset. 💰 ❗️I just would like to highlight that these results didn’t come out of nowhere. They are coming out of huge resilience of the leaders such as Maciej Wieczorek or Pawel Przewiezlikowski that show that right planning will get you to success (depending on how one defines one). This resilience and trust are what keep me also pushing on forward #polishbiotech and showcasing it on the global scene 🌎 - with small steps & with big help of people thinking alike 💪 I am aware that Polish biotech companies still have long way to go to be compared to international players in the field, but I strongly believe that #cooperation will get us there and this is what Central European BioForum stands for. 🎯I hope to see everyone interested in #biotech #business on at #CEBioForum2025📍2-3 APRIL / Warsaw Photo credit: Aleksander Kłósek at #BIO2024

Exciting insights from our recent roundtables, hosted in partnership with @AusBiotech. We were joined by more than 90 Biotech CEOs to discuss funding challenges, navigating regulatory changes, and talent acquisition. Read more about our discussions and how we can support your journey: https://lnkd.in/gwNc4P48

Our Better Biotech Growth webinar series kicks off this September! Join Simone Seiter and Kevin Baruzzi as they reveal how to transform scientific innovations into market successes. Learn to create a winning product strategy and integrate key insights from various stakeholders to achieve commercial excellence. Don't miss this opportunity! Register now: skp.link/rw7l #BetterBiotechGrowth #Biotech #CommercialExcellence #SimonKucher #BiotechGrowth

Want to stay ahead in the biotech industry? Subscribe to Fierce Biotech Newsletters for the latest breakthroughs and industry updates straight to your inbox. Industry professionals and leaders rely on the awards winning Fierce Biotech to make informed decisions and lead impactful conversations. Don't miss out on staying informed and ahead of the curve. What biotech trend are you following this year? Follow Fierce Biotech 🔗https://hubs.ly/Q02HZQ9R0 #FierceBiotech #BiotechNews #IndustryUpdates #StayInformed

Innovation sciences have advanced in recent years due to creation of the most extensive business innovation database, InnoSurvey® (+5,000 companies in 105 countries). This allowed us to see correlations between leadership styles, cultures, capabilities, and company growth. It's helpful to look into this new data and see how it can inform your company's innovation management processes. This new methodology will be presented at the event in Lyon. Get more info and register here: https://lnkd.in/gcrA9aen #innovationinhealthcare #innovationmanagement #lyon #france2030 #pharma #biotech #medtech #digitalhealth #innovation